Aurinia Pharmaceuticals (AUPH) Shares Outstanding (2016 - 2026)

Aurinia Pharmaceuticals (AUPH) has 11 years of Shares Outstanding (Entity) data on file, last reported at $130.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) fell 5.06% year-over-year to $130.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $130.8 million (down 5.06% YoY) and the FY2025 annual result came in at $132.3 million, down 6.08% from the prior year.
• Shares Outstanding (Entity) eased to $130.8 million in Q1 2026, from $132.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $143.8 million in Q4 2023 to a low of $130.8 million in Q1 2026.
• A 5-year average of $139.9 million and a median of $142.1 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) climbed 10.63% — and 2025, when it fell 7.87%.
• Tracing AUPH's Shares Outstanding (Entity) over 5 years: stood at $142.3 million in 2022, then advanced by 1.1% to $143.8 million in 2023, then decreased by 2.05% to $140.9 million in 2024, then dropped by 6.08% to $132.3 million in 2025, then slipped by 1.17% to $130.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $130.8 million (Q1 2026), $132.3 million (Q4 2025), and $131.8 million (Q3 2025), per Business Quant data.